Stéphanie Germon

991 total citations
14 papers, 726 citations indexed

About

Stéphanie Germon is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Stéphanie Germon has authored 14 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in Stéphanie Germon's work include Toxoplasma gondii Research Studies (5 papers), Herpesvirus Infections and Treatments (4 papers) and Virus-based gene therapy research (4 papers). Stéphanie Germon is often cited by papers focused on Toxoplasma gondii Research Studies (5 papers), Herpesvirus Infections and Treatments (4 papers) and Virus-based gene therapy research (4 papers). Stéphanie Germon collaborates with scholars based in France, United States and Sudan. Stéphanie Germon's co-authors include Mark B. Feinberg, Rafi Ahmed, Mark J. Mulligan, Carlos del Rı́o, Srilatha Edupuganti, Joseph D. Miller, David Masopust, Silvija I. Staprans, John D. Altman and Kaja Murali‐Krishna and has published in prestigious journals such as SHILAP Revista de lepidopterología, Immunity and Journal of Molecular Biology.

In The Last Decade

Stéphanie Germon

14 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphanie Germon France	8	377	214	206	192	165	14	726
Kimberly Schmitt United States	14	290 0.8×	341 1.6×	276 1.3×	268 1.4×	137 0.8×	37	755
Diego A. Vargas‐Inchaustegui United States	16	455 1.2×	242 1.1×	97 0.5×	232 1.2×	109 0.7×	36	796
Hugues Fausther‐Bovendo Canada	14	287 0.8×	150 0.7×	349 1.7×	176 0.9×	150 0.9×	32	757
Jennifer L. Yates United States	14	352 0.9×	73 0.3×	252 1.2×	378 2.0×	92 0.6×	31	782
Maureen F. Maughan United States	12	360 1.0×	226 1.1×	314 1.5×	253 1.3×	268 1.6×	17	840
Caroline Blondeau France	11	230 0.6×	292 1.4×	169 0.8×	228 1.2×	176 1.1×	13	582
Phil Felgner United States	9	350 0.9×	232 1.1×	161 0.8×	311 1.6×	331 2.0×	13	854
Laurie R. Gray United States	13	195 0.5×	122 0.6×	127 0.6×	81 0.4×	118 0.7×	21	725
Kathrine Hansen Denmark	5	600 1.6×	121 0.6×	163 0.8×	194 1.0×	298 1.8×	5	730
Kenichiro Murata Japan	8	414 1.1×	125 0.6×	99 0.5×	238 1.2×	192 1.2×	19	722

Countries citing papers authored by Stéphanie Germon

Since Specialization

Citations

This map shows the geographic impact of Stéphanie Germon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Germon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Germon more than expected).

Fields of papers citing papers by Stéphanie Germon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Germon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Germon. The network helps show where Stéphanie Germon may publish in the future.

Co-authorship network of co-authors of Stéphanie Germon

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Germon. A scholar is included among the top collaborators of Stéphanie Germon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Germon. Stéphanie Germon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Mévélec, Marie-Noëlle, Louis Lantier, Laurie Lajoie, et al.. (2025). Neospora caninum as delivery vehicle for anti-PD-L1 scFv-Fc: A novel approach for cancer immunotherapy. PubMed. 33(2). 200968–200968. 1 indexed citations

Lantier, Louis, Anne Di Tommaso, Laurie Lajoie, et al.. (2023). Nasal administration of recombinant Neospora caninum secreting IL-15/IL-15Rα inhibits metastatic melanoma development in lung. Journal for ImmunoTherapy of Cancer. 11(5). e006683–e006683. 6 indexed citations

Lantier, Louis, Anne Di Tommaso, Stéphanie Germon, et al.. (2021). Abstract 1712: Neospora caninum: An immunotherapeutic protozoan against cancer. Cancer Research. 81(13_Supplement). 1712–1712. 2 indexed citations

Lantier, Louis, Anne Di Tommaso, Mathieu Epardaud, et al.. (2020). Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer. Journal for ImmunoTherapy of Cancer. 8(2). e001242–e001242. 13 indexed citations

Lantier, Louis, Anne Di Tommaso, Stéphanie Germon, et al.. (2020). 846 Neospora caninum – an immunotherapeutic protozoan against solid cancers. SHILAP Revista de lepidopterología. A504–A505. 3 indexed citations

Carpentier, Rodolphe, Isabelle Lantier, Stéphanie Germon, et al.. (2017). Synthetic Parasites: A Successful Mucosal Nanoparticle Vaccine Against Toxoplasma Congenital Infection in Mice. Future Microbiology. 12(5). 393–405. 24 indexed citations

Akbar, Haroon, Stéphanie Germon, Patricia Berthon, Isabelle Dimier‐Poisson, & Nathalie Moiré. (2012). Depletion of CD25+ cells during acute toxoplasmosis does not significantly increase mortality in Swiss OF1 mice. Memórias do Instituto Oswaldo Cruz. 107(2). 155–162. 4 indexed citations

Dion, Sarah, et al.. (2011). Functional activation of T cells by dendritic cells and macrophages exposed to the intracellular parasite Neospora caninum. International Journal for Parasitology. 41(6). 685–695. 26 indexed citations

Bischerour, Julien, Stéphanie Germon, Jérôme Guillard, et al.. (2009). First Mariner Mos1 Transposase Inhibitors (Supplementary Data). Mini-Reviews in Medicinal Chemistry. 9(4). 431–439. 4 indexed citations

10.

Germon, Stéphanie, et al.. (2009). Mariner Mos1 transposase optimization by rational mutagenesis. Genetica. 137(3). 265–276. 18 indexed citations

11.

Miller, Joseph D., Robbert van der Most, Rama Akondy, et al.. (2008). Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines. Immunity. 28(5). 710–722. 420 indexed citations

12.

Augé‐Gouillou, Corinne, et al.. (2005). Mariner Mos1 Transposase Dimerizes Prior to ITR Binding. Journal of Molecular Biology. 351(1). 117–130. 38 indexed citations

13.

Silvestri, Guido, Andrew Fedanov, Stéphanie Germon, et al.. (2005). Divergent Host Responses during Primary Simian Immunodeficiency Virus SIVsm Infection of Natural Sooty Mangabey and Nonnatural Rhesus Macaque Hosts. Journal of Virology. 79(7). 4043–4054. 153 indexed citations

14.

Zoulim, Fabien, Pascale Berthillon, B. Seignères, et al.. (2002). Animal models for the study of HBV infection and the evaluation of new anti‐HBV strategies. Journal of Gastroenterology and Hepatology. 17(s4). S460–3. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact